Rhesus disease: Postnatal management and outcome

European Journal of Pediatrics

Volumn 158, Issue 9, 1999, Pages 689-693

  Greenough, A ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Jaundice; Rhesus disease

Indexed keywords

BILIRUBIN; HEME OXYGENASE INHIBITOR; IMMUNOGLOBULIN; PHENOBARBITAL;

ANEMIA; EXCHANGE BLOOD TRANSFUSION; HEMOLYSIS; HUMAN; HYDROPS; HYPERBILIRUBINEMIA; HYPOGLYCEMIA; INFANT MORTALITY; KERNICTERUS; PHOTOTHERAPY; POSTNATAL CARE; PRIORITY JOURNAL; REVIEW; RHESUS INCOMPATIBILITY; TREATMENT OUTCOME;

BLOOD TRANSFUSION; BLOOD TRANSFUSION, INTRAUTERINE; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; MALE; PHOTOTHERAPY; PREGNANCY; RH ISOIMMUNIZATION;

EID: 0032798710     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310051180     Document Type: Review

References (58)

1. 1. Allen FH, Diamond LK, Vaughan VC (1950) Erythroblastosis fetalis VI. Prevention of kemicterus. Am J Dis Child 80:779
2. 2. Aranda JV, Sweet AY (1977) Alterations in blood pressure during exchange transfusion. Arch Dis Child 52:545-548
3. 3. Ayyash H, Hadjigeorgiou E, Sofatzis J, Chatziioannou A, Nicolopoulos D, Sideris E (1987) Green light phototherapy in newborn infants with ABO haemolytic disease. J Pediatr 111:882-887
4. 4. Bada HS, Chua C, Salmon JH, Hajjar W (1979) Changes in intracranial pressure during exchange transfusion. J Pediatr 94:129-132
5. 5. Beckman H, Jakob H (1991) Prenatal disturbances of nerve cell migration in the entorhinal region: a common vulnerability factor in functional psychoses? J Neural Transm 84:155-164
6. 6. Berger HM, Lindeman JHN, van Zoeren-Grobben D, Houdkamp E, Schrijver J, Kanhai HH (1990) Iron overload, free radical damage and rhesus haemolytic disease. Lancet 335:933-936
7. 7. Berlin G, Selbing A, Ryden GSO (1985) Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin. Lancet 1:1153
8. 8. Blackburn MG, Orzalesi MM, Pigram P (1972) The combined effect of phototherapy and phenobarbital on serum bilirubin levels of premature infants. Pediatrics 49:110-112
9. 9. Carlton DP, McGillivray BC, Schreiber MD (1989) Non-immune hydrops fetalis: a multidisciplinary approach. Clin Perinatol 16:839-851
10. 10. Chamberlain D, Hislop A, Hey E, Reid LSO (1977) Pulmonary hypoplasia in babies with severe rhesus isoimmunisation: a quantitative study. J Pathol 122:43-52
11. 11. Christensen RD, Liechty KW, Koenig JM, Schibler KR, Ohls RKSO (1991) Administration of erythropoietin to newborn rats results in diminished neutrophil production. Blood 78:1241-1246
12. 12. Clarke C, Hussey RMSO (1994) Decline in deaths from rhesus haemolytic disease of the newborn. J R Coll Physicians Lond 28:310-311
13. 13. Copelan EA, Strohm PL, Kennedy MS, Tutschka PJSO (1986) Hemolysis following intravenous immune globulin therapy. Transfusion 26:410-412
14. 14. Ebbesen F (1979) Superiority of intensive phototherapy - blue double light - in rhesus haemolytic disease. Eur J Pediatr 130:279-284
15. 15. Ennever JF (1990) Blue light, great light, white light, more light: treatment of neonatal jaundice. Clin Perinatol 17:467-483
16. 16. Fehr J, Hofmann V, Kappeler USO (1982) Transient reversal of thrombocytopenia in idiopathic thrombocytopenia purpura by high-dose intravenous gamma globulin. N Engl J Med 306:1254-1258
17. 17. Greenough A, Yüksel B, Nicolaides KH (1994) Abnormalities of lung volume at follow up following antenatal rhesus isoimmunization. Acta Paediatr 83:498-500
18. 18. Hayde M, Widness JA, Pollak C, Kohlhauser-Vollmuth C, Vreman HJ, Stevenson DK (1997) Rhesus isoimmunization: increased-hemolysis during early infancy. Pediatr Res 41:716-721
19. 19. Hollister JM, Laing P, Mednick SA (1996) Rhesus incompatibility as a risk factor for schizophrenia in male adults. Arch Gen Psychiatry 53:19-24
20. 20. Holzgreve W, Holzgreve B, Curry CJR (1985) Non-immune hydrops fetalis: diagnosis and management. Semin Perinatol 9:52-67
21. 21. Johnston WH, Angara V, Baumal R, et al (1967) Erythroblastosis fetalis and hyperbilirubinaemia: a five-year follow up with neurological psychological and audiological evaluation. Pediatrics 39:88-92
22. 22. Kanhai HH, van Kamp IK, Moolenaar AJ, Gravenhorst JB (1990) Transplacental passage of digoxin in severe rhesus isoimmunization. J Perinat Med 18:339-343
23. 23. Kappas A, Drummond GS, Manola T, Petmezaki S, Valaes T (1988) Snprotoporphyrin use in the management of hyperbilirubinaemia in term newborns with direct Coombs-positive ABO incompatibility. Pediatrics 81:485-497
24. 24. Kirsten GF, Steyn DW, Muller L, et al (1995) The outcome of babies of mothers with severe rhesus incompatibility treated at Tygerberg Hospital, 1980-1993. S Afr Med J 85:1091-1096
25. 25. Lindeman JHN, Lentjes EGWM, Houdkamp E, van Zoeren-Grobben D, Schrijver J, Berger HM (1992) Effect of an exchange transfusion on plasma antioxidants in the newborn. Pediatrics 90:200-203
26. 26. Luban NLC, De Palma L (1996) Transfusion associated graft versus host disease in the neonate - expanding the spectrum of disease. Transfusion 36:101-103
27. 27. Lucey JF, Dangman B (1984) A re-examination of the role of oxygen in retrolental fibroplasia. Pediatrics 73:92-96
28. 28. Maisels MJ (1994) Jaundice. In: Avery GB, Fletcher MA, MacDonald MG (eds) Neonatology, pathophysiology and management of the newborn. Lippincott, Philadelphia
29. 29. McMullin GP, Hayes MF, Arora SC (1970) Phenobarbitone in rhesus haemolytic disease: a controlled trial. Lancet 2:949-952
30. 30. McNeil TF (1988) Obstetric factors and perinatal injuries. In: Tsuang MT, Simpson JC (eds) Handbook of schizophrenia: nosology, epidemiology and genetics. Elsevier Science, Amsterdam, pp 319-344
31. 31. Meloni T, Costa S, Dare A, et al (1978) Phototherapy for neonatal hyperbilirubinaemia in mature newborns with erythrocyte G6PD deficiency. Biol Neonate 34:295
32. 32. Millard DD, Gidding SS, Socol ML, et al (1990) Effects of intravascular, intrauterine transfusion on prenatal and postnatal haemolysis and erythropoiesis in severe fetal isoimmunisation. J Pediatr 117:447-454
33. 33. Mollison PL, Walker W (1952) Controlled trials of the treatment of haemolytic disease of the newborn. Lancet 262:429
34. 34. Naiman JL, Punnett HH, Lischner HW, Destine ML, Arey JB (1969) Possible graft versus host reaction after intrauterine transfusion for Rh erythroblastosis fetalis. N Engl J Med 281:697-701
35. 35. Newman TB, Klebanoff MA (1993) Neonatal hyperbilirubinemia and long term outcome: another look at the collaborative perinatal project. Pediatrics 92:651-657
36. 36. Nilsen ST, Finne PH, Bergsjo P, Stamnes O (1984) Males with neonatal hyperbilirubinaemia examined at 18 years of age. Acta Paediatr Scand 73:176-180
37. 37. Ohto H, Andersen KCSO (1996) Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients. Transfus Med Rev 10:31-43
38. 38. Ovali F, Samanci N, Dagoglu T (1996) Management of late anemia in rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study). Pediatr Res 39:831-834
39. 39. Parkman R, Mosier D, Umansky J, et al (1974) Graft versus host disease after intrauterine and exchange transfusions for haemolytic disease of the newborn. N Engl J Med 290:359
40. 40. Peterec SM (1995) Management of neonatal Rh disease. Clin Perinatol 22:561-592
41. 41. Phibbs RH, Johnson P, Tooley WH (1974) Cardiorespiratory status of erythroblastic newborn infants. II. Blood volume, hematocrit and serum albumin concentration in relation to hydrops fetalis. Pediatrics 53:13-23
42. 42. Phibbs RJ, Johnson P, Kitterman JA, Gregory GA, Tooley WH, Schlueter M (1976) Cardiorespiratory status of erythroblastic newborn infants. III. Intravascular pressures during the first hours of life. Pediatrics 58:484-493
43. 43. Rübo J, Albrecht K, Lasch P, et al (1992) High-dose intravenous immune globulin therapy for hyperbiliruinemia caused by Rh hemolytic disease. J Pediatr 121:93-97
44. 44. Ruys JH, van Gelderen HH (1962) Administration of albumin in exchange transfusion. J Pediatr 61:413
45. 45. Scaradavou A, Inglis S, Peterson P, Dunne J, Chervenak F, Bussel J (1993) Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: use of erythropoietin to treat the late anemia. J Pediatr 123:279-284
46. 46. Sisson TRC, Kendall N, Glauser SC, Knutson S, Bunyaviroch E (1971) Phototherapy of jaundice in newborn infants. I. ABO blood group incompatibility. J Pediatr 79:904-910
47. 47. Steinke J, Gries FA, Driscoll SG (1967) In vitro studies of insulin inactivation with reference to erythroblastosis fetalis. Blood 30:359-363
48. 48. Stewart G, Day RE, Priore C, Del Whittle MJ, Turner TL, Holland BM (1994) Development outcome after intravascular intrauterine transfusion for rhesus haemolytic disease. Arch Dis Child 70:F52-F53
49. 49. Thompson PJ, Greenough A, Brooker R, Nicolaides KH, Gamsu HR (1993) Antenatal diagnosis and outcome in hydrops fetalis. J Perinat Med 21:63-67
50. 50. Urbaniak SJSO (1979) ADCC (K-cell) lysis of human erythrocytes sensitized with rhesus alloantibodies. II. Investigation into the mechanism of lysis. Br J Haematol 42:315-325
51. 51. Valaes T, Kipouros K, Petmezaki S, et al (1980) Effectiveness and safety of prenatal phenobarbital for the prevention of neonatal jaundice. J Pediatr 14:947-952
52. 52. Valdes OS, Maurer HM, Shumway CN, Draper DA, Hossaini AA (1971) Controlled clinical trial of phenobarbital and/or light in reducing neonatal hyperbilirubinaemia in a predominantly Negro population. J Pediatr 79:1015-1017
53. 53. Van de Bor M, Benders MJNL, Dorrepall CA, Van Bel F, Brand R (1994) Cerebral blood volume changes during exchange transfusions in infants born at or near term. J Pediatr 125:617-621
54. 54. Van Maldergen L, Jauniaux E, Fourneau C, Gillerot Y (1992) Genetic causes of hydrops fetalis. Pediatrics 89:81-86
55. 55. Voto LS, Sexer H, Ferreiro G, et al (1995) Neonatal administration of high dose intravenous immunoglobulin in rhesus haemolytic disease. J Perinat Med 23:443-451
56. 56. Waters WJ, Porter E (1964) Indications for exchange transfusion based upon the role of albumin in the treatmentt of haemolytic disease of the newborn. Pediatrics 33:749
57. 57. Whitfield CR, Raffat A, Urbaniak S (1997) Underreporting of mortality from RhD haemolytic disease in Scotland and its implications: retrospective review. BMJ 315:1504-1505
58. 58. Whittle MJSO (1992) Rhesus haemolytic disease. Arch Dis Child 67:65-68